Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

8 Aug 2012 07:00

RNS Number : 5235J
Avon Rubber PLC
08 August 2012
 



Strictly embargoed until 07:00 Wednesday 8 August 2012

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 APRIL 2012 TO 7 AUGUST 2012

Protection & Defence

In Protection & Defencethe full yearorder intake for the Division is expected to be 38% up on the previous year and with a significant element of this for delivery in future years, we have improved visibility of revenues from both the DoD and commercial customers for 2013.

 

Orders in hand from the US Department of Defense (DoD) will allow us to deliver similar volumes of the M50 respirator in the second half of our 2012 financial year to the first half of the year. As expected we have seen an acceleration in the delivery of spare filters to the DoD since the half year, albeit the overall level of filter orders will be below that of the previous year. We expect filter demand to grow as more mask systems are delivered although customer scheduling of filter deliveries remains difficult to predict.

 

Project Fusion, our new program to expand and enhance our product range, remains on track to provide further organic growth from 2013/4.

 

Dairy

In Dairy we have seen further growth in sales of our Milk-Rite brand, in particular the Impulse Mouthpiece Vented Liner. Our sales and distribution centre in China is progressing well, in line with expectations.

 

Net debt

The Group's balance sheet remains robust. Net debt at 30 June 2012 was £10.2m (30 September 2011: £11.8m) reflecting the timing of working capital movements and the significant investment made in product development during the year. 

 

Outlook

The business as a whole has progressed further in this period with continued investment in product development and our brands and distribution channels. With improved operational performance from Protection & Defence and the Dairy business performing strongly, we continue to expect that the results for the second half of the year will be stronger than the first half with year on year growth comparable with the level seen during the first half.

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896870

Sarah Matthews-DeMers, Group Financial Controller

01225 896835

Miles Ingrey-Counter, Company Secretary

01225 896850

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

 

 

 

 

  

 

 

 

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological,Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder,

emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced

CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised

solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and

tubing for the automated milking process. For further information please visit the Group's website www.avon‐rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSSAFMWFESEDA
Date   Source Headline
27th Sep 20077:01 amRNSAppointments
14th Sep 20077:00 amRNSMoU for Turkish Supply
3rd Sep 200710:30 amRNSTotal Voting Rights
21st Aug 20071:39 pmRNSHolding(s) in Company
3rd Aug 200710:04 amRNSHolding(s) in Company
1st Aug 20072:06 pmRNSTotal Voting Rights
29th Jun 200711:49 amRNSTotal Voting Rights
19th Jun 20077:01 amRNSShare Ownership Trust
18th Jun 20071:42 pmRNSHolding(s) in Company
13th Jun 20074:09 pmRNSShare Ownership Trust
1st Jun 200710:02 amRNSTotal Voting Rights
31st May 20077:02 amRNSInterim Report
17th May 20077:01 amRNSInterim Results
17th May 20077:01 amRNSBoard Appointment
1st May 20079:42 amRNSTotal Voting Rights
30th Apr 20074:36 pmRNSNotice of Results
25th Apr 20079:29 amRNSBlocklisting Interim Review
5th Apr 20074:15 pmRNSHolding(s) in Company
4th Apr 20076:03 pmRNSHolding(s) in Company
2nd Apr 20077:02 amRNSTrading Update
30th Mar 20072:17 pmRNSHolding(s) in Company
16th Mar 200710:10 amRNSHolding(s) in Company
13th Mar 20073:26 pmRNSHolding(s) in Company
9th Mar 200712:59 pmRNSHolding(s) in Company - Amend
8th Mar 20072:45 pmRNSHolding(s) in Company
1st Mar 20079:08 amRNSTotal Voting Rights
6th Feb 200712:41 pmRNSManagement Change
6th Feb 20079:48 amRNSAdditional Listing
1st Feb 20072:41 pmRNSTotal Voting Rights
30th Jan 20071:03 pmRNSHolding(s) in Company
25th Jan 200712:30 pmRNSAnnual General Meeting
25th Jan 20077:01 amRNSAGM Statement
19th Jan 200711:29 amRNSHolding(s) in Company
18th Jan 200711:46 amRNSTotal Voting Rights
12th Jan 200710:00 amRNSAnnual Information Update
5th Jan 200712:51 pmRNSDirector/PDMR Shareholding
3rd Jan 20074:20 pmRNSHolding(s) in Company
22nd Dec 20068:31 amRNSAnnual Report and Accounts
20th Dec 20063:05 pmRNSDirector/PDMR Shareholding
19th Dec 20062:54 pmRNSHolding(s) in Company
14th Dec 200610:55 amRNSDirector/PDMR Shareholding
14th Dec 200610:05 amRNSDirector/PDMR Shareholding
14th Dec 20067:01 amRNSBoard Changes
12th Dec 20062:27 pmRNSHolding(s) in Company
8th Dec 20064:27 pmRNSTotal Voting Rights
5th Dec 200612:12 pmRNSHolding(s) in Company
1st Dec 20062:24 pmRNSDividend Declaration
30th Nov 20067:03 amRNSFinal Results
7th Nov 20061:01 pmRNSNotice of Results
1st Nov 20062:07 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.